DARKPOOL0.1.0
AFT-MKT Sign in
OMDA
Omada Health, Inc.
NMS Equity
15.24
+0.18 (+1.20%)
52w low 10.28 25.45 high
32.7% of range
Open
15.10
High
15.63
Low
15.10
Prev Close
15.06
Volume
1.21M
Avg Vol 3M
1.30M
Market Cap
945.45M
Currency
USD

6 Month Trend

full chart ›
— C-- Chg-- Gap-- Vol-- ×avg-- σ-- SMA20-- SMA50-- SMA200-- RSI-- SPY-- DD-- Bench-- Sig-- Hist-- hover · click to pin · ← → step · drag to zoom · shift-drag to measure
15.0020.0025.00May 26Jun 26Jul 26Aug 26Sep 26Nov 26
—Context
  • Move across the chart.

Company

SectorHealthcare
IndustryHealth Information Services
CountryUnited States
Employees980
Website ↗

Performance

change over each horizon
1D +1.20%
5D -21.56%
1M -30.32%
3M -36.07%
6M -4.99%
YTD -3.42%
1Y -26.77%
2Y --
3Y --
5Y --
MAX -16.72%

Technical Rating

704 daily bars
Sell
0 bullish 5 bearish 1 neutral
SignalReading
− Price vs 50-day average 15.24 vs 19.31
− Price vs 200-day average 15.24 vs 20.97
− 50-day vs 200-day 19.31 vs 20.97
− MACD histogram -0.390
− 3-month rate of change -22.9%
· RSI (14) 31.4 (neutral)

A mechanical summary of past prices only — six indicators, one vote each. It uses no fundamentals, no news and no knowledge of your circumstances, and the signals disagree by design. Not investment advice.

ML Prediction

704 daily bars
BUY
SignalReading
Predicted next close 16.00
Predicted change +5.00%
Trend DOWN
Support / Resistance 14.90 / 21.24
Track record 100% of 1 provisional
  • model: +5.0%
  • downtrend confirmed
  • near support

A mechanical fit to past prices, nothing more — no fundamentals, no news, no view of your circumstances. Historically close to a coin flip on direction (see the backtest). Not investment advice.

Valuation

P/E Trailing37.65x
P/E Forward22.67x
Price / Book3.42x
Price / Sales2.81x
EV / EBITDA52.81x
EPS Trailing0.40
Dividend Yield0.00%
Beta--

Profitability

Gross Margin70.69%
Operating Margin2.06%
Net Margin4.21%
Return on Equity5.72%
Return on Assets1.35%
Revenue Growth+34.20%
Debt / Equity--
Current Ratio4.18x

Business

Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care. The company offers its programs for employers, health plans and systems, and pharmacy benefits managers through its direct sales force and channel partners. The company was incorporated in 2011 and is headquartered in South San Francisco, California.